普通人群吸烟与慢性肾脏病:前瞻性队列研究的系统综述与Meta分析
该系统综述与Meta分析纳入15项前瞻性队列研究、共65 064例新发慢性肾脏病(CKD)病例,评估普通成人吸烟与CKD风险的关系。结果显示,与从不吸烟者相比,曾吸烟者、当前吸烟者和既往吸烟者新发CKD的风险均升高;当前吸烟者发生终末期肾病的风险也升高。合并3项额外队列研究后,普通人群中吸烟与蛋白尿无显著关联。
要点
- 与从不吸烟者相比,曾吸烟者新发CKD的风险升高(SRR 1.27,95%CI 1.19-1.35)。
- 当前吸烟者新发CKD的SRR为1.34(95%CI 1.23-1.47),既往吸烟者为1.15(95%CI 1.08-1.23)。
- 当前吸烟者发生终末期肾病的SRR为1.91(95%CI 1.39-2.64),曾吸烟者为1.51(95%CI 1.24-1.84)。
核心结论
- 本Meta分析提示,吸烟可能是普通人群新发CKD的独立危险因素。
- 未来需要研究戒烟能否降低普通成人新发CKD的风险。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE和Embase自建库至2016年5月31日的前瞻性队列研究。
- 共纳入15项前瞻性队列研究,包含65 064例新发CKD病例;合并3项额外前瞻性队列研究(涉及5747例新发蛋白尿病例)分析吸烟与蛋白尿的关联。
- 采用随机效应模型计算汇总相对危险度(SRR)和95%置信区间(CI)。
主要发现
- 与从不吸烟者相比,曾吸烟者新发CKD的SRR为1.27(95%CI 1.19-1.35)。
- 与从不吸烟者相比,当前吸烟者新发CKD的SRR为1.34(95%CI 1.23-1.47),既往吸烟者为1.15(95%CI 1.08-1.23)。
- 与从不吸烟者相比,曾吸烟者发生终末期肾病的SRR为1.51(95%CI 1.24-1.84)。
- 与从不吸烟者相比,既往吸烟者发生终末期肾病的SRR为1.44(95%CI 1.00-2.09),当前吸烟者为1.91(95%CI 1.39-2.64)。
- 合并3项额外前瞻性队列研究(5747例新发蛋白尿病例)后,普通人群中吸烟与蛋白尿无显著关联。
局限性
- 原文报告这些研究间存在 considerable heterogeneity(显著异质性)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cigarette smoking has been established as a major risk factor for chronic kidney disease (CKD) development in people with diabetes. Conflicting evidence exists among representative community-based studies as to whether smoking is an independent risk factor for CKD. The aim of this meta-analysis was to assess the effects of tobacco smoking on the development of CKD in adult general populations. METHODS: A literature search was conducted using MEDLINE and Embase from their inception through 31 May 2016 for prospective cohort studies that reported relative risks of CKD with smoking status in the general population. Summary relative risks (SRRs) and 95% confidence intervals (CIs) were calculated using a random effects model. RESULTS: A total of 15 prospective cohort studies, including 65 064 incident CKD cases, were included. Compared with never-smokers, the SRRs of incident CKD were 1.27 (95% CI 1.19-1.35) for ever-smokers, 1.34 (95% CI 1.23-1.47) for current smokers and 1.15 (95% CI 1.08-1.23) for former smokers. The SRRs for end-stage renal disease development were 1.51 (95% CI 1.24-1.84) for ever-smokers, 1.44 (95% CI 1.00-2.09) for former smokers and 1.91 (95% CI 1.39-2.64) for current smokers. Considerable heterogeneity was observed among these studies. After combining an additional three prospective cohort studies, which involved 5747 incident proteinuria cases, a null smoking-proteinuria association in the general population was observed. CONCLUSIONS: Our meta-analysis suggests evidence for cigarette smoking as an independent risk factor for incident CKD. Future studies are required to investigate whether smoking cessation can decrease incident CKD in the general adult population.
引用
- Xia J, Wang L, Ma Z, et al. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017. PMID: 28339863. doi:10.1093/ndt/gfw452
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。